CUMYL-THPINACA

CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid.[1] CUMYL-THPINACA acts as a potent agonist for the cannabinoid receptors, with approximately 6x selectivity for CB1, having an EC50 of 0.1nM for human CB1 receptors and 0.59nM for human CB2 receptors.[2]

CUMYL-THPINACA
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC23H27N3O2
Molar mass377.5 g/mol g·mol−1
3D model (JSmol)

Sweden's public health agency suggested to classify CUMYL-THPINACA as hazardous substance on November 10, 2014.[3]

As of October 2015 CUMYL-THPINACA is a controlled substance in China.[4]

See also

References
  1. "CUMYL-THPINACA". Cayman Chemical. Retrieved 11 July 2015.
  2. Bowden; et al. (11 April 2013). "Patent WO 2014167530 - Cannabinoid compounds". New Zealand Patent application 623626. Retrieved 11 July 2015.
  3. "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015.
  4. "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.